Inhibition of endocannabinoid-degrading enzyme fatty acid amide hydrolase increases atherosclerotic plaque vulnerability in mice

Journal of Molecular and Cellular Cardiology

Volumn 66, Issue , 2014, Pages 126-132

  Hoyer, Friedrich Felix ^a   Khoury, Mona ^a   Slomka, Heike ^a   Kebschull, Moritz ^a   Lerner, Raissa ^b   Lutz, Beat ^b   Schott, Hans ^a   Lütjohann, Dieter ^a   Wojtalla, Alexandra ^a   Becker, Astrid ^a   Zimmer, Andreas ^a   Nickenig, Georg ^a  

^a UNIVERSITY OF BONN   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Fatty acid amide hydrolase; URB597; Vascular inflammation

Indexed keywords

ANANDAMIDE; COLLAGEN; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; FATTY ACID AMIDASE; GELATINASE B; SUPEROXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROTIC PLAQUE; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; ENZYME INHIBITION; FATTY ACID BLOOD LEVEL; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; VASCULITIS;

MUS;

ATHEROSCLEROSIS; FATTY ACID AMIDE HYDROLASE; URB597; VASCULAR INFLAMMATION;

AMIDOHYDROLASES; ANIMALS; APOLIPOPROTEINS E; ARACHIDONIC ACIDS; BENZAMIDES; CARBAMATES; CELL MOVEMENT; DIET, HIGH-FAT; DIETARY FATS; ENDOCANNABINOIDS; ENZYME INHIBITORS; GENE EXPRESSION; MACROPHAGES; MICE; MICE, KNOCKOUT; NEUTROPHILS; PLAQUE, ATHEROSCLEROTIC; POLYUNSATURATED ALKAMIDES; SUPEROXIDES;

EID: 84889979627     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2013.11.013     Document Type: Article

References (30)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999, 340:115-126.
2. Hansson G.K. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005, 352:1685-1695.
3. Dutta P., Courties G., Wei Y., Leuschner F., Gorbatov R., Robbins C.S., et al. Myocardial infarction accelerates atherosclerosis. Nature 2012, 487:325-329.
4. Mach F., Steffens S. The Role of the endocannabinoid system in atherosclerosis. J Neuroendocrinol 2008, 20:53-57.
5. Steffens S., Veillard N.R., Arnaud C., Pelli G., Burger F., Staub C., et al. Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice. Nature 2005, 434:782-786.
6. Xu H., Cheng C.L., Chen M., Manivannan A., Cabay L., Pertwee R.G., et al. Anti-inflammatory property of the cannabinoid receptor-2-selective agonist JWH-133 in a rodent model of autoimmune uveoretinitis. J Leukoc Biol 2007, 82:532-541.
7. Malfait A.M., Gallily R., Sumariwalla P.F., Malik A.S., Andreakos E., Mechoulam R., et al. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis. Proc Natl Acad Sci U S A 2000, 97:9561-9566.
8. Sanchez A.J., Gonzalez-Perez P., Galve-Roperh I., García-Merino A. R-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)-pyrrolo-[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphtalenylmethanone (WIN-2) ameliorates experimental autoimmune encephalomyelitis and induces encephalitogenic T cell apoptosis: partial involvement of the CB(2) receptor. Biochem Pharmacol 2006, 72:1697-1706.
9. Arevalo-Martin A., Vela J.M., Molina-Holgado E., Borrell J., Guaza C. Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci 2003, 23:2511-2516.
10. Pertwee R.G. Pharmacological actions of cannabinoids. Handb Exp Pharmacol 2005, 168:1-51.
11. Schlosburg J.E., Kinsey S.G., Lichtman A.H. Targeting fatty acid amide hydrolase (FAAH) to treat pain and inflammation. AAPS J 2009, 11:39-44.
12. Bátkai S., Pacher P., Osei-Hyiaman D., Radaeva S., Liu J., Harvey-White J., et al. Hypertension endocannabinoids acting at cannabinoid-1 receptors regulate cardiovascular function in hypertension. Circulation 2004, 110:1996-2002.
13. Justinova Z., Mangieri R.A., Bortolato M., Chefer S.I., Mukhin A.G., Clapper J.R., et al. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Biol Psychiatry 2008, 64:930-937.
14. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., et al. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 2001, 98:9371-9376.
15. Chang L., Luo L., Palmer J.A., Sutton S., Wilson S.J., Barbier A.J., et al. Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms. Br J Pharmacol 2006, 148:102-113.
16. Piomelli D., Tarzia G., Duranti A., Tontini A., Mor M., Compton T.R., et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597). CNS Drug Rev 2006, 12:21-38.
17. Russo R., Loverme J., La Rana G., Compton T.R., Parrott J., Duranti A., et al. The fatty acid amide hydrolase inhibitor URB597 reduces neuropathic pain after oral administration in mice. J Pharmacol Exp Ther 2007, 322:236-242.
18. Montecucco F., Burger F., Mach F., Steffens S. CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. Am J Physiol Heart Circ Physiol 2008, 294:H1145-H1155.
19. Zhao Y., Yuan Z., Liu Y., Xue J., Tian Y., Liu W., et al. Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules. J Cardiovasc Pharmacol 2010, 55:292-298.
20. Hoyer F.F., Steinmetz M., Zimmer S., Becker A., Lütjohann D., Buchalla R., et al. Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo. J Mol Cell Cardiol 2011, 51:1007-1014.
21. Montecucco F., Di Marzo V., da Silva R.F., Vuilleumier N., Capettini L., Lenglet S., et al. The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. Eur Heart J 2012, 33:846-856.
22. Dol-Gleizes F., Paumelle R., Visentin V., Marés A.M., Desitter P., Hennuyer N., et al. Rimonabant a selective cannabinoid CB1 receptor antagonist, inhibits atherosclerosis in LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 2009, 29:12-18.
23. Tiyerili V., Zimmer S., Jung S., Wassmann K., Naehle C.P., Lütjohann D., et al. CB1 receptor inhibition leads to decreased vascular AT1 receptor expression, inhibition of oxidative stress and improved endothelial function. Basic Res Cardiol 2010, 105:465-477.
24. Vilela L.R., Medeiros D.C., Rezende G.H., de Oliveira A.C., Moraes M.F., Moreira F.A. Effects of cannabinoids and endocannabinoid hydrolysis inhibition on pentylenetetrezole-induced seizure and electroencephalographic activity in rats. Epilepsy Res 2013, 104:195-202.
25. Moreira F.A., Kaiser N., Monory K., Lutz B. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Neuropharmacology 2008, 54:141-150.
26. Murphy N., Cowley T.R., Blau C.W., Dempsey C.N., Noonan J., Gowran A., et al. The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation. J Neuroinflammation 2012, 9:79.
27. Bátkai S., Rajesh M., Mukhopadhyay P., Haskó G., Liaudet L., Cravatt B.F., et al. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am J Physiol Heart Circ Physiol 2007, 293:H909-H918.
28. Mukhopadhyay P., Horváth B., Rajesh M., Matsumoto S., Saito K., Bátkai S., et al. Fatty acid amide hydrolase is a key regulator of endocannabinoid induced myocardial tissue injury. Free Radic Biol Med 2011, 50:179-195.
29. Sugamura K., Sugiyama S., Nozaki T., Matsuzawa Y., Izumiya Y., Miyata K., et al. Activated endocannabinoid system in coronary artery disease and antiinflammatory effects of cannabinoid 1 receptor blockade on macrophages. Circulation 2009, 119:28-36.
30. Miyashita K., Oyama T., Sakuta T., Tokuda M., Torii M. Anandamide induces matrix metalloproteinase-2 production through cannabinoid-1 receptor and transient receptor potential vanilloid-1 in human dental pulp cells in culture. J Endod 2012, 38:786-790.